Study of the Efficacy and Safety of Ponsegromab in Patients With Cancer, Cachexia and Elevated GDF-15
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Non-small Cell Lung Cancer
Related studies linked through entity extraction aliases.
A Study of BMS-986442 With Nivolumab With or Without Chemotherapy in Solid Tumors and Non-small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
PLAsma Genomic Testing in Patients With Advanced Non-Small Cell Lung Cancer: The PLAN Study
- Status
- RECRUITING
- Phase
- N/A
A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Tissue Eosinophils in Non-Small Cell Lung Cancer (the TEN Study)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Envafolimab Immunotherapy After ctDNA EGFR Clearance by Treatment With Almonertinib in EGFR-Mutant, PD-LI Positive NSCLC
- Status
- UNKNOWN
- Phase
- PHASE2
Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE3
Phase I/IIa Study of H002 in NSCLC With Active EGFR Mutation
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Multicenter Prospective Study to Assess the Effects of Adjuvant Icotinib in EGFRm Stage I NSCLC With High-risk of Disease Recurrence After Complete Resection
- Status
- UNKNOWN
- Phase
- PHASE2
Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Ensartinib in Combination With Bevacizumab in ALK-positive NSCLC Patients With TP53 Mutation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
ctDNA as a Biomarker for Treatment in Advanced NSCLC
- Status
- UNKNOWN
- Phase
- N/A
Anlotinib , Penpulimab Combined With SBRT for Metastatic Non-Small Cell Lung Cancer (NSCLC)
- Status
- UNKNOWN
- Phase
- PHASE2
Lazertinib/Pemetrexed/Carboplatin After Osimertinib Failure in NSCLC With Brain Metastases
- Status
- UNKNOWN
- Phase
- PHASE2
Sintilimab Combined With Anlotinib for Perioperative Non-small Cell Lung Cancer Based on MRD Evaluation
- Status
- UNKNOWN
- Phase
- PHASE2
Correlation Between Efficacy of Osimertinib and EGFR T790M Status and Ratio Via ddPCR in NSCLC
- Status
- UNKNOWN
- Phase
- PHASE2
Combining ICI With SBRT or HypoFrx-RT for ES NSCLC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Association Between the Results of Specific Genetic Tests and the Efficacy of Targeted Therapies in Patients
- Status
- COMPLETED
- Phase
- N/A
Adjuvant Furmonertinib in Stage IA With High Risk Factors and Stage IB Non-small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2